Upstream Bio, Inc. (UPB) Insider Trading
Directors, officers and holders of more than 10% of UPB report their trades in its stock on SEC Form 4, within two business days. Each row below is one Form 4 transaction line. The one-letter code says what kind of transaction it was: only P (purchase) and S (sale) are open-market or private trades; awards, option exercises, tax withholding and gifts carry other codes.
Recent Form 4 transactions
The 50 most recent of 72 transactions on file: 2 with code P, 15 with code S and 33 with other codes.
| Date | Insider | Title | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 16, 2026 | Houghton Adam | Chief Business Officer | S Sale | 700 | $5.49 | $3,843 |
| Sep 16, 2026 | Sutherland Everett Rand | Chief Executive Officer | S Sale | 2,095 | $5.49 | $11,502 |
| Sep 16, 2026 | Deykin Aaron | Chief Medical Officer | S Sale | 895 | $5.49 | $4,914 |
| Sep 16, 2026 | Ambrose Allison | General Counsel | S Sale | 485 | $5.49 | $2,663 |
| Sep 16, 2026 | GRAY MICHAEL | CFO and COO | S Sale | 853 | $5.49 | $4,683 |
| Jun 16, 2026 | GRAY MICHAEL | CFO and COO | S Sale | 853 | $6.10 | $5,203 |
| Jun 16, 2026 | Sutherland Everett Rand | Chief Executive Officer | S Sale | 2,095 | $6.10 | $12,780 |
| Jun 16, 2026 | Houghton Adam | Chief Business Officer | S Sale | 700 | $6.10 | $4,270 |
| Jun 16, 2026 | Deykin Aaron | Chief Medical Officer | S Sale | 895 | $6.10 | $5,460 |
| Jun 16, 2026 | Ambrose Allison | General Counsel | S Sale | 477 | $6.10 | $2,910 |
| Jun 9, 2026 | Ratcliffe Liam | Director | A Award | 17,096 | Not measured | Not measured |
| Jun 9, 2026 | Beckman Daniella | Director | A Award | 17,096 | Not measured | Not measured |
| Jun 9, 2026 | Fleming Harold Edward | Director | A Award | 17,096 | Not measured | Not measured |
| Jun 9, 2026 | Renaud Ronald C JR | Director | A Award | 17,096 | Not measured | Not measured |
| Jun 9, 2026 | Ruddy Marcella K. | Director | A Award | 17,096 | Not measured | Not measured |
| Jun 9, 2026 | Chimovits Erez | Director | A Award | 17,096 | Not measured | Not measured |
| Mar 16, 2026 | Houghton Adam | Chief Business Officer | S Sale | 699 | $9.29 | $6,494 |
| Mar 16, 2026 | GRAY MICHAEL | CFO and COO | S Sale | 852 | $9.29 | $7,915 |
| Mar 16, 2026 | Deykin Aaron | Chief Medical Officer | S Sale | 894 | $9.29 | $8,305 |
| Mar 16, 2026 | Sutherland Everett Rand | Chief Executive Officer | S Sale | 2,093 | $9.29 | $19,444 |
| Mar 16, 2026 | Ambrose Allison | General Counsel | S Sale | 475 | $9.29 | $4,413 |
| Jan 2, 2026 | GRAY MICHAEL | CFO and COO | A Award | 30,500 | Not measured | Not measured |
| Jan 2, 2026 | Deykin Aaron | Chief Medical Officer | A Award | 32,000 | Not measured | Not measured |
| Jan 2, 2026 | Ambrose Allison | General Counsel | A Award | 17,000 | Not measured | Not measured |
| Jan 2, 2026 | Houghton Adam | Chief Business Officer | A Award | 25,000 | Not measured | Not measured |
| Jan 2, 2026 | Sutherland Everett Rand | Chief Executive Officer | A Award | 75,000 | Not measured | Not measured |
| Jan 2, 2026 | GRAY MICHAEL | CFO and COO | A Award | 91,500 | Not measured | Not measured |
| Jan 2, 2026 | Deykin Aaron | Chief Medical Officer | A Award | 96,000 | Not measured | Not measured |
| Jan 2, 2026 | Ambrose Allison | General Counsel | A Award | 51,000 | Not measured | Not measured |
| Jan 2, 2026 | Houghton Adam | Chief Business Officer | A Award | 75,000 | Not measured | Not measured |
| Jan 2, 2026 | Sutherland Everett Rand | Chief Executive Officer | A Award | 225,000 | Not measured | Not measured |
| Jun 10, 2025 | Ratcliffe Liam | Director | A Award | 17,096 | Not measured | Not measured |
| Jun 10, 2025 | Ruddy Marcella K. | Director | A Award | 17,096 | Not measured | Not measured |
| Jun 10, 2025 | Beckman Daniella | Director | A Award | 17,096 | Not measured | Not measured |
| Jun 10, 2025 | Renaud Ronald C JR | Director | A Award | 17,096 | Not measured | Not measured |
| Jun 10, 2025 | Chimovits Erez | Director | A Award | 17,096 | Not measured | Not measured |
| Jun 10, 2025 | Fleming Harold Edward | Director | A Award | 17,096 | Not measured | Not measured |
| Feb 6, 2025 | Sutherland Everett Rand | Chief Executive Officer | A Award | 500,000 | Not measured | Not measured |
| Feb 6, 2025 | Ambrose Allison | General Counsel | A Award | 25,000 | Not measured | Not measured |
| Feb 6, 2025 | Deykin Aaron | Chief Medical Officer | A Award | 165,000 | Not measured | Not measured |
| Feb 6, 2025 | Houghton Adam | Chief Business Officer | A Award | 140,000 | Not measured | Not measured |
| Feb 6, 2025 | GRAY MICHAEL | CFO and COO | A Award | 195,000 | Not measured | Not measured |
| Dec 16, 2024 | Ambrose Allison | General Counsel | A Award | 100,000 | Not measured | Not measured |
| Oct 15, 2024 | ORBIMED ADVISORS LLC | Director | C Conversion | 789,833 | Not measured | Not measured |
| Oct 15, 2024 | Wellington Biomedical Innovation Master Investors (Cayman) II L.P. | 10% Owner | C Conversion | 852,940 | Not measured | Not measured |
| Oct 15, 2024 | Wellington Biomedical Innovation Master Investors (Cayman) II L.P. | 10% Owner | C Conversion | 894,733 | Not measured | Not measured |
| Oct 15, 2024 | AI Upstream LLC | 10% Owner | C Conversion | 1,172,410 | Not measured | Not measured |
| Oct 15, 2024 | AI Upstream LLC | 10% Owner | C Conversion | 3,147,000 | Not measured | Not measured |
| Oct 15, 2024 | AI Upstream LLC | 10% Owner | P Purchase | 1,175,000 | $17.00 | $19,975,000 |
| Oct 15, 2024 | ORBIMED ADVISORS LLC | Director | P Purchase | 660,000 | $17.00 | $11,220,000 |
The full Form 4 history is on the UPB company page (Insider Trades card, View all).
Questions about this data
Which insider transactions are open-market trades?
Code P (open market or private purchase) and code S (open market or private sale). Code F is shares withheld to pay tax on vesting stock, A is an award from the company, M and X are option exercises and G is a gift. None of those is the insider choosing to buy or sell in the market.
How quickly are insider trades reported?
A Form 4 is due before the end of the second business day after the trade. The date shown is the transaction date from the form.
Who has to file Form 4?
Officers, directors and beneficial owners of more than 10% of a class of the company’s registered equity, under Section 16 of the Securities Exchange Act.
Look up any code in the Form 4 transaction code reference, or read Form 4 codes explained.